Inhibition of specific NOX isoforms as a new treatment for hypertensive and diabetic retinopathy

  • Wilkinson-Berka, Jennifer (Primary Chief Investigator (PCI))
  • Appukuttan, Binoy (Chief Investigator (CI))
  • Schmidt, Harald, (Chief Investigator (CI))
  • Smith, Justine, (Chief Investigator (CI))

Project: Research

StatusFinished
Effective start/end date1/01/1531/12/18

Funding

  • National Health & Medical Research Council (NHMRC): AUD823,372.00